The owner of Kleenex and Huggies will acquire the embattled company, which has fought claims by the Trump administration that a common pain reliever is linked to harmful side effects.
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...